Innovative Cell Therapies RoslinCT specializes in advanced cell and gene therapy development with a strong track record of pioneering treatments like CRISPR-edited therapies, offering opportunities to collaborate on cutting-edge therapeutic projects.

Global Manufacturing Capacity With purpose-built cGMP facilities in both Scotland and the US, RoslinCT provides scalable manufacturing services, making it an ideal partner for companies seeking reliable, high-quality clinical and commercial production of cell therapies.

Strategic Collaborations Recent partnerships with industry leaders like Vertex Pharmaceuticals highlight RoslinCT’s ability to co-develop complex therapies, presenting opportunities to engage with their expanding pipeline and collaborative initiatives.

Leadership & Expansion New key appointments, including high-profile board members and operations leaders, signify growth and strategic direction, making the company a compelling target for suppliers and technology providers looking to support expanding capacities.

Market Differentiation RoslinCT’s heritage in pioneering stem cell and gene editing technologies positions it as a leader in the competitive biotech space, opening opportunities for advanced biotech tools, analytical services, and innovative solutions to enhance their R&D and manufacturing workflows.